Vaccine candidate of Biological E is in it phase-1 clinical trials while Gennovabiopharmaceuticals is in the process of getting approvals at various levels. Serum Institute of India (SII) is also conducting phase 2 and 3 clinical trials of the Oxford-Astrazeneca vaccine.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.